Coloplast A/S, a leading global healthcare company headquartered in Denmark (DK), specialises in innovative medical devices and services for individuals with intimate healthcare needs. Founded in 1957, Coloplast has established a strong presence in Europe, North America, and Asia, focusing on areas such as ostomy care, continence care, and wound and skin care. The company is renowned for its commitment to user-friendly products, including advanced ostomy bags and continence management solutions that enhance the quality of life for patients. Coloplast's dedication to research and development has positioned it as a market leader, with notable achievements in product innovation and patient support services. With a strong emphasis on sustainability and social responsibility, Coloplast continues to make significant strides in the healthcare industry, ensuring that individuals receive the best possible care.
How does Coloplast's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Coloplast's score of 67 is higher than 98% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Coloplast A/S reported total carbon emissions of approximately 219,118,000 kg CO2e. This includes 21,282,000 kg CO2e from Scope 1 emissions, which encompass direct emissions from owned or controlled sources, and 21,670,000 kg CO2e from Scope 2 emissions, related to indirect emissions from the generation of purchased electricity. The majority of their emissions, about 197,836,000 kg CO2e, fall under Scope 3, which includes emissions from the entire value chain, such as business travel and purchased goods and services. Coloplast has set ambitious climate commitments, aiming to achieve a 100% reduction in absolute Scope 1 and 2 greenhouse gas emissions by FY2030, using FY2019 as the baseline. Additionally, they plan to reduce Scope 3 emissions by 50% per product manufactured by FY2030. The company is also committed to sourcing 100% renewable electricity annually through 2025. These targets align with the Science Based Targets initiative (SBTi) and are designed to support global efforts to limit warming to 1.5°C. Overall, Coloplast's proactive approach to reducing its carbon footprint reflects its commitment to sustainability and environmental responsibility within the healthcare equipment and supplies sector.
Access structured emissions data, company-specific emission factors, and source documents
2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 15,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 2 | 36,404,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | - | - | - | - | - | 00,000 |
Scope 3 | 7,398,000 | 0,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Coloplast is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.